ATE185606T1 - Monoklonale antikörper gegen putative hcv-e2/ns1- proteine und verfahren zu ihrer verwendung - Google Patents
Monoklonale antikörper gegen putative hcv-e2/ns1- proteine und verfahren zu ihrer verwendungInfo
- Publication number
- ATE185606T1 ATE185606T1 AT92920089T AT92920089T ATE185606T1 AT E185606 T1 ATE185606 T1 AT E185606T1 AT 92920089 T AT92920089 T AT 92920089T AT 92920089 T AT92920089 T AT 92920089T AT E185606 T1 ATE185606 T1 AT E185606T1
- Authority
- AT
- Austria
- Prior art keywords
- monoclonal antibodies
- methods
- proteins
- antibodies against
- putative hcv
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 241000711549 Hepacivirus C Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003149 assay kit Methods 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/748,292 US5308750A (en) | 1989-12-22 | 1991-08-21 | Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE185606T1 true ATE185606T1 (de) | 1999-10-15 |
Family
ID=25008836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92920089T ATE185606T1 (de) | 1991-08-21 | 1992-08-21 | Monoklonale antikörper gegen putative hcv-e2/ns1- proteine und verfahren zu ihrer verwendung |
Country Status (9)
Country | Link |
---|---|
US (1) | US5308750A (de) |
EP (1) | EP0603307B1 (de) |
JP (1) | JP3335351B2 (de) |
AT (1) | ATE185606T1 (de) |
AU (1) | AU2585092A (de) |
CA (1) | CA2115923A1 (de) |
DE (1) | DE69230146T2 (de) |
ES (1) | ES2139607T3 (de) |
WO (1) | WO1993004205A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0273115B1 (de) * | 1986-10-22 | 1994-09-07 | Abbott Laboratories | Chemilumineszierende Acridinium- und Phenantridiniumsalze |
US5683864A (en) * | 1987-11-18 | 1997-11-04 | Chiron Corporation | Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
US6312889B1 (en) | 1990-04-04 | 2001-11-06 | Chiron Corporation | Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
US6274148B1 (en) * | 1990-11-08 | 2001-08-14 | Chiron Corporation | Hepatitis C virus asialoglycoproteins |
CA2129733C (en) * | 1992-01-31 | 2006-10-31 | James M. Casey | Mammalian expression systems for hcv proteins |
CA2162557C (en) | 1993-05-12 | 2004-09-28 | Amy J. Weiner | Conserved motif of hepatitis c virus e2/ns1 region |
US5824507A (en) * | 1994-05-20 | 1998-10-20 | Genelabs Technologies, Inc. | Hepatitis G virus and molecular cloning thereof |
JP3217600B2 (ja) * | 1994-07-12 | 2001-10-09 | 株式会社先端生命科学研究所 | 非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ |
EP1211315A1 (de) * | 1994-07-29 | 2002-06-05 | Innogenetics N.V. | Rekombinante Vektoren zur Herstellung von HCV Hüllproteinen |
US20040185061A1 (en) * | 1994-07-29 | 2004-09-23 | Innogenetics N.V. | Redox reversible HCV proteins with native-like conformation |
CN1044384C (zh) * | 1994-08-25 | 1999-07-28 | 中国药品生物制品检定所 | 抗丙型肝炎病毒抗原单克隆抗体细胞株建立及其单克隆抗体 |
GB9517926D0 (en) | 1995-09-01 | 1995-11-01 | Biocine Spa | Binding protein |
US6747136B2 (en) * | 1996-04-19 | 2004-06-08 | Karolinska Innovations Ab | Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
US6538114B1 (en) | 1996-04-19 | 2003-03-25 | Karolina Innovations Ab | Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
JPH10136990A (ja) * | 1996-09-18 | 1998-05-26 | Boehringer Mannheim Gmbh | G型肝炎ウイルスに対する抗体、hgvの診断検出のた めのおよび治療薬としてのその使用 |
GB9624165D0 (en) * | 1996-11-19 | 1997-01-08 | Amdex A S | Use of nucleic acids bound to carrier macromolecules |
EP0947525A1 (de) | 1998-03-27 | 1999-10-06 | Innogenetics N.V. | Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe |
US7108855B2 (en) * | 1998-06-24 | 2006-09-19 | Innogenetics N.V. | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
US7091324B2 (en) * | 1998-11-05 | 2006-08-15 | Board Of Trustees Of Leland Stanford Junior University | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
CA2380777C (en) * | 1999-07-28 | 2011-01-04 | Chiron Corporation | Hepatitis c viral antigen immunoassay detection systems |
US6815160B1 (en) | 1999-07-28 | 2004-11-09 | Chiron Corporation | Hepatitis C viral antigen immunoassay detection systems |
WO2002036833A1 (en) * | 2000-11-06 | 2002-05-10 | Bio-Tech Imaging, Inc. | Method and kits for detecting hepatitis infected cells |
AU2002243259B2 (en) * | 2000-12-01 | 2008-02-07 | The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Monoclonal antibodies specific for the E2 glycoprotein of hepatitis C virus and their use in the diagnosis, treatment, and prevention of hepatitis C |
US7101561B2 (en) | 2000-12-01 | 2006-09-05 | Innogenetics N.V. | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
GB0112652D0 (en) * | 2001-05-24 | 2001-07-18 | Inst Of Molecul & Cell Biology | Internalisation of virus into cells |
US7858752B2 (en) * | 2006-12-05 | 2010-12-28 | Abbott Laboratories | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same |
NZ579706A (en) | 2007-02-21 | 2012-03-30 | Univ Massachusetts | Human antibodues against hepatitis C virus (HCV) E2 protein and uses thereof |
US20080227111A1 (en) * | 2007-03-16 | 2008-09-18 | Sysmex Corporation | Reagent kit and method for measuring hcv antibody |
EP2201023A2 (de) * | 2007-09-14 | 2010-06-30 | GENimmune N.V. | Affinitäts-tag |
US20100104555A1 (en) * | 2008-10-24 | 2010-04-29 | The Scripps Research Institute | HCV neutralizing epitopes |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ227011A (en) * | 1987-11-18 | 1992-03-26 | Chiron Corp | Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits |
HUT54896A (en) * | 1989-03-17 | 1991-04-29 | Chiron Corp | Process for producing aquous diagnosticum and vaccine of nanbv |
AU638304B2 (en) * | 1989-12-22 | 1993-06-24 | Abbott Laboratories | Hepatitis c assay |
US5106726A (en) * | 1990-02-16 | 1992-04-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV |
EP0464287A1 (de) * | 1990-06-25 | 1992-01-08 | The Research Foundation for Microbial Diseases of Osaka University | Non-A, Non-B Hepatitis Virus genomisches DNS und Antigenpolypeptide |
CA2047792C (en) * | 1990-07-26 | 2002-07-02 | Chang Y. Wang | Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
CA2049679C (en) * | 1990-08-24 | 2005-06-21 | Sushil G. Devare | Hepatitis c assay utilizing recombinant antigens |
-
1991
- 1991-08-21 US US07/748,292 patent/US5308750A/en not_active Expired - Lifetime
-
1992
- 1992-08-21 CA CA002115923A patent/CA2115923A1/en not_active Abandoned
- 1992-08-21 EP EP92920089A patent/EP0603307B1/de not_active Expired - Lifetime
- 1992-08-21 AT AT92920089T patent/ATE185606T1/de not_active IP Right Cessation
- 1992-08-21 AU AU25850/92A patent/AU2585092A/en not_active Abandoned
- 1992-08-21 WO PCT/US1992/007189 patent/WO1993004205A1/en active IP Right Grant
- 1992-08-21 JP JP50465993A patent/JP3335351B2/ja not_active Expired - Fee Related
- 1992-08-21 DE DE69230146T patent/DE69230146T2/de not_active Expired - Fee Related
- 1992-08-21 ES ES92920089T patent/ES2139607T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0603307A1 (de) | 1994-06-29 |
EP0603307B1 (de) | 1999-10-13 |
CA2115923A1 (en) | 1993-03-04 |
JPH06510192A (ja) | 1994-11-17 |
JP3335351B2 (ja) | 2002-10-15 |
DE69230146T2 (de) | 2000-05-25 |
AU2585092A (en) | 1993-03-16 |
ES2139607T3 (es) | 2000-02-16 |
DE69230146D1 (de) | 1999-11-18 |
US5308750A (en) | 1994-05-03 |
EP0603307A4 (de) | 1995-01-18 |
WO1993004205A1 (en) | 1993-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE185606T1 (de) | Monoklonale antikörper gegen putative hcv-e2/ns1- proteine und verfahren zu ihrer verwendung | |
DK0765478T3 (da) | Positiv og positiv/negativ celleselektion medieret af peptidfrigørelse | |
ATE171472T1 (de) | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 | |
FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
ATE239756T1 (de) | Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag) | |
FI942369A (fi) | Hepatitis-C-virustesti | |
DE69932812D1 (de) | Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe | |
NO20051715L (no) | HCV assay | |
DK1200126T3 (da) | Anvendelse af CD28-specifikke monoklonale antistoffer til fremstilling af en farmaceutisk sammensætning til behandling af virusinfektioner | |
ATE167522T1 (de) | Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen | |
DE69224134D1 (de) | Monoklonale Antikörper gegen Hepatitis-C-Virus | |
ATE202117T1 (de) | Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma | |
DE69227776D1 (de) | Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden | |
ATE178096T1 (de) | Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen | |
ATE294237T1 (de) | S?ugetier thymokingene | |
Suzuki et al. | Idiotypic and fine specificity analysis of a (4‐hydroxy‐3‐nitrophenyl) acetyl (NP)‐specific suppressor T cell hybridoma at the level of cell surface structures, isolated receptor material and functional suppressor factor | |
KR950700423A (ko) | 씨(c)형 간염 비루스에 대한 단일클론 항체 및 항-유전자형 항체(monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus) | |
DE60029570D1 (de) | Verfahren zur isolierung der cd8+-zellen, und entsprechende hybridomazellen, antikörper und polypeptide | |
KR900700135A (ko) | 광견병 비루스 세포를 특이적으로 인지하는 사람 모노클로날 항체, 이의 생성세포, 그 항체를 함유하는 제제 및 이들의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |